hero section gradient
15 handpicked stocks

Soundtrack of Our Lives

Tap into the complete value chain of the global music industry with this expertly curated portfolio. From streaming platforms to concert promoters and audio technology innovators, these companies capture the enduring power of music as both a cultural phenomenon and economic growth engine.

Author avatar

Han Tan | Market Analyst

Published on June 18

Your Basket's Financial Footprint

Concise market-cap summary for the 'Soundtrack of Our Lives' basket and investor takeaways.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and more market-like performance, likely reducing idiosyncratic risk.
  • Best used as a core holding within diversified portfolios rather than a short-term speculative position.
  • Expect steady, long-term value growth rather than rapid, explosive short-term gains; returns may be gradual.
Total Market Cap
  • SPOT: $141.09B

  • LYV: $36.87B

  • WMG: $17.43B

  • Other

About This Group of Stocks

1

Our Expert Thinking

Music is more than entertainment—it's a passion-driven economic force. This portfolio spans the entire ecosystem that produces, distributes, and monetizes music globally. It's designed to capture revenue from digital streaming subscriptions, live experiences, content rights, and the technology that delivers sound to our ears.

2

What You Need to Know

This collection represents a diverse cross-section of the music business, from industry giants to innovative disruptors. It includes streaming platforms, major record labels, concert promoters, and audio hardware manufacturers. Consider this a cultural and growth-oriented component for a well-rounded investment portfolio.

3

Why These Stocks

These companies were carefully selected to represent market leaders and innovators across the music landscape. They're positioned to benefit from expanding global subscriber bases for streaming services and the high-margin return of live music experiences—two powerful catalysts driving the industry forward.

Why You'll Want to Watch These Stocks

🎧

Never Stops Playing

Music consumption is resilient through economic cycles—people don't unsubscribe from their favorite streaming services even during tough times. This creates stable revenue streams unaffected by market volatility.

🎪

The Live Experience Comeback

After pandemic shutdowns, live concerts and festivals have returned with record-breaking demand and ticket prices. Companies in this space are seeing unprecedented revenue as fans flock to irreplaceable in-person experiences.

💰

Streaming's Untapped Global Potential

Only a fraction of the world's population currently pays for music streaming. As internet access expands and middle classes grow in developing countries, streaming platforms have massive subscriber growth potential ahead.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions